FDA Plans Acute Stroke Device Workshop; Guidance Could Follow
This article was originally published in The Gray Sheet
Executive Summary
The October workshop will focus discussion on clinical study trial designs, patient populations, and patient selection methods, as well as study endpoints for devices targeting ischemic stroke, FDA says.
You may also be interested in...
Top Device Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014
The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to an analysis of CMS' Open Payments database.
Top Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014
The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to a "Gray Sheet" analysis of CMS' Open Payments database.
Experts Recommend Requiring Randomized Trials For Flow Diverter PMAs
FDA's Neurological Devices Panel says sponsors should be required to conduct randomized controlled trials for aneurysm treatment devices such as flow diverters and should only be allowed to use performance goal studies as a last resort to support approval.